Go To Content
  • facebook
  • Google
  • Line
  • Twitter
  • Forward
  • Print

Guidance, Law & Regulations

Announcement of the “Implementation details and transition periods of the Western Pharmaceuticals Good Distribution Practice (GDP) Regulations for drug dealers engaged in active pharmaceutical ingredients (APIs) storage and transportation” and takes effect from its issued date.

【Update Date:2020-10-06】 unit:品質監督管理組
【Announced Date:2020-10-06】
【Amended Date:2020-10-06】
Ministry of Health and Welfare Official Announcement

Issue Date: July 27, 2020
Issue No.: MOHW1091104030

Subject: Announcement of the “Implementation details and transition periods of the Western Pharmaceuticals Good Distribution Practice (GDP) Regulations for drug dealers engaged in active pharmaceutical ingredients (APIs) storage and transportation” and takes effect from its issued date.

Legal basis: Paragraph 2 of Article 53-1 of Pharmaceutical Affairs Act

Announcement elements: From the date of this announcement, the dealers whose business undertakings engaged in wholesaling, importing and exporting active pharmaceutical ingredients (APIs) shall apply for GDP inspection to Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare (MOHW) and comply with the Western Pharmaceuticals Good Distribution Practice (GDP) Regulations by December 31, 2022.